{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:56:14Z","timestamp":1760820974997},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.transproceed.2018.01.028","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T07:15:12Z","timestamp":1523085312000},"page":"1050-1055","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus"],"prefix":"10.1016","volume":"50","author":[{"given":"K.","family":"Nanmoku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shinzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.01.028_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.tp.0000173647.43616.78","article-title":"Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression","volume":"80","author":"Shimmura","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.028_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2006.01676.x","article-title":"Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation\u2014single center analysis","volume":"7","author":"Ishida","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib3","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/ajt.12313","article-title":"Association between steroid dosage and death with a functioning graft after kidney transplantation","volume":"13","author":"Opelz","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib4","doi-asserted-by":"crossref","first-page":"SS3","DOI":"10.1097\/01.TP.0000069952.49242.3E","article-title":"New-onset diabetes after transplantation: 2003 International consensus guidelines","volume":"75","author":"Davidson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.028_bib5","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Patient survival after renal transplantation: IV. Impact of post-transplant diabetes","volume":"62","author":"Cosio","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.01.028_bib6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.TP.0000140969.43761.1F","article-title":"Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials","volume":"78","author":"Pascual","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.028_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A\u00a0randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.trre.2015.09.001","article-title":"Everolimus immunosuppression in kidney transplantation: what is the optimal strategy?","volume":"30","author":"Witzke","year":"2016","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2018.01.028_bib9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/TP.0b013e3182230900","article-title":"Everolimus and long-term outcomes in renal transplantation","volume":"92","author":"Campistol","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.028_bib10","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.transproceed.2017.04.017","article-title":"Effective and safe reduction of conventional immunosuppressants using everolimus in maintenance kidney transplant recipients","volume":"49","author":"Nanmoku","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.01.028_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/ajt.13649","article-title":"Impact of everolimus and low-dose cyclosporin on cytomegalovirus replication and disease in pediatric renal transplantation","volume":"16","author":"H\u00f6cker","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib12","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.transproceed.2018.01.028_bib13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrneph.2015.144","article-title":"Strategies to overcome the ABO barrier in kidney transplantation","volume":"11","author":"B\u00f6hmig","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2018.01.028_bib14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/JCM.30.5.1232-1237.1992","article-title":"Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia","volume":"30","author":"Gerna","year":"1992","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.transproceed.2018.01.028_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2018.01.028_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ctr.12281","article-title":"Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study","volume":"28","author":"Uchida","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ctr.12624","article-title":"De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation","volume":"29","author":"Koch","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/tri.12718","article-title":"Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and\/or viremia","volume":"29","author":"Belliere","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.01.028_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tid.12601","article-title":"Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients","volume":"18","author":"Pascual","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.028_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.028_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/tri.12330","article-title":"Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies","volume":"27","author":"Croze","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.01.028_bib23","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/ajt.12852","article-title":"Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: a systematic review and meta-analysis","volume":"14","author":"Murakami","year":"2014","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518300964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518300964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T08:02:48Z","timestamp":1604131368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518300964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0041134518300964"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.028","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}